Asthma & Allergies
» Should a Patient with a 2 cm HER2+/TNBC Clinically Node Negative Receive Neoadjuvant Therapy?
Should a Patient with a 2 cm HER2+/TNBC Clinically Node Negative Receive Neoadjuvant Therapy?
May 9, 2019
Enhancing Supportive Care for Pediatric Patients with High-Risk Neuroblastoma: A Focus on Nursing Practice Strategies
2018 Webinar: Controversies in Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
Combination Therapy for Invasive Aspergillosis in Patients with Hematologic Malignancies or Hematopoeitic Cell Transplants
Post a comment to this article
(will not be displayed)
Report Abusive Comment
Thank you for helping us to improve our forums. Is this comment offensive? Please tell us why.